Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Severe combined immunodeficiency (SCID) is a life-threatening genetic disorder characterized by profound defects in the immune system.
• Infants with SCID are highly vulnerable to severe, recurrent infections, leading to high mortality without timely immune reconstitution.
• Current diagnostic methods often identify SCID only after infants develop symptomatic infections, particularly in the absence of newborn screening programs.

Purpose of the Study:

• To evaluate the potential benefits of early detection of SCID through pre-symptomatic screening.
• To assess the proportion of SCID cases that could benefit from earlier diagnosis.
• To understand the impact of SCID on families and the availability of treatment facilities.

Main Methods:

• A survey was conducted with parents of children diagnosed with SCID.
• The survey collected data on family history, pre- and post-diagnosis events, treatment outcomes, and the overall impact of SCID on families.
• Analysis focused on comparing outcomes for infants diagnosed at different stages.

Main Results:

• Infants diagnosed with SCID as neonates demonstrated significantly better survival rates compared to those diagnosed later.
• Early diagnosis via screening highlights the potential to avert severe infections and improve long-term outcomes.
• Parental perspectives underscore the value of timely detection for managing SCID.

Conclusions:

• Universal newborn screening for SCID offers a critical opportunity for early detection and intervention.
• Pre-symptomatic screening can lead to improved survival and better treatment outcomes for affected infants.
• Implementing widespread SCID newborn screening is recommended to enhance pediatric health outcomes.